Psyence Biomedical (PBM) Accounts Payables (2023 - 2025)

Psyence Biomedical's Accounts Payables history runs 3 years deep, the most recent figure standing at $261937.0 for Q1 2025.

• In Q1 2025, Accounts Payables fell 53.42% year-over-year to $261937.0; the TTM figure through Mar 2025 stood at $261937.0 (down 53.42% YoY), while the FY2025 annual figure was $261937.0, down 53.42% from the prior year.
• Accounts Payables was $261937.0 for Q1 2025 at Psyence Biomedical, down from $562352.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.8 million in Q1 2023 to a low of $261937.0 in Q1 2025.
• Historically, Accounts Payables has averaged $871663.0 across 3 years, with a median of $562352.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Accounts Payables sank 68.6% in 2024, then slumped 53.42% in 2025.
• A 3-year view of Accounts Payables shows it stood at $1.8 million in 2023, then tumbled by 68.6% to $562352.0 in 2024, then plunged by 53.42% to $261937.0 in 2025.
• The last three Accounts Payables figures came in at $261937.0 (Q1 2025), $562352.0 (Q1 2024), and $1.8 million (Q1 2023), per Business Quant data.